IP Library Assignment 026422/0892
Patent Assignment
Reel/Frame 026422/0892

Assignment of Assignor's Interest

Recorded: 2011-06-09 Pages: 11
Assignors
MARSAULT, ERIC
Executed: 2011-04-18
BENAKLI, KAMEL
Executed: 2011-04-26
HOVEYDA, HAMID R.
Executed: 2011-05-16
PETERSON, MARK L.
Executed: 2011-04-14
BEAUBIEN, SYLVIE
Executed: 2011-04-29
OUELLET, LUC
Executed: 2011-05-02
ST-LOUIS, CARL
Executed: 2011-05-03
BEAUCHEMIN, SOPHIE
Executed: 2011-05-05
Assignee
TRANZYME PHARMA INC.
3001 12E AVENUE NORD IPS, QUEBEC, J1H 5N4, CANADA
Covered Property (1)
Spatially-Defined Macrocyclic Compounds Useful for Drug Discovery
Patent: 8,440,851 →
Application: 13/036,204 →
Publication: US 2011/0237785
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 17, 2014
From: TRANZYME PHARMA INC.
To: OCERA THERAPEUTICS, INC.
Reel/Frame 031994/0084 →
Notice of Grant of Security Interest in Intellectual Property Dec 22, 2017
From: OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 044949/0634 →
Release of Patent Security Interests Recorded at Reel 044949, Frame 0634 Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0460 →